Borosil Scientific Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements

Technical Trends Shift to Mildly Bullish

The primary catalyst for the upgrade was a notable change in Borosil Scientific’s technical grade, which moved from a sideways trend to a mildly bullish stance. Weekly technical indicators such as the Moving Average Convergence Divergence (MACD) and the Know Sure Thing (KST) oscillator have turned mildly bullish, signalling potential upward momentum in the near term. The On-Balance Volume (OBV) indicator also supports this positive outlook, showing bullish trends on both weekly and monthly charts, suggesting accumulation by investors.

However, some mixed signals remain. While Bollinger Bands on the weekly chart are mildly bullish, the monthly view is mildly bearish, and daily moving averages continue to show a mildly bearish trend. The Relative Strength Index (RSI) remains neutral with no clear signal on both weekly and monthly timeframes. Dow Theory analysis indicates no clear trend weekly but a mildly bullish trend monthly, reinforcing the cautious optimism among technical analysts.

Overall, the technical picture has improved enough to justify a more positive stance, but the presence of some bearish elements advises prudence.

Financial Performance Shows Encouraging Signs

Borosil Scientific reported a strong rebound in its Q3 FY25-26 results, marking a return to profitability after two consecutive quarters of negative performance. The company posted a Profit Before Tax excluding Other Income (PBT LESS OI) of ₹12.15 crores, representing a remarkable growth of 154.5% compared to the previous four-quarter average. Operating profit before depreciation and interest (PBDIT) reached a quarterly high of ₹17.19 crores, while the operating profit margin to net sales improved to 14.17%, the highest in recent quarters.

Additionally, the company remains net-debt free, which strengthens its balance sheet and reduces financial risk. This debt-free status is a positive factor for investors seeking stability in a micro-cap industrial products company.

Quality and Management Efficiency Remain Concerns

Despite the improved financial results, Borosil Scientific’s management efficiency continues to lag behind industry standards. The company’s average Return on Equity (ROE) stands at a modest 4.53%, indicating relatively low profitability generated from shareholders’ funds. This figure suggests that while the company is profitable, it is not optimally utilising its equity base to generate returns.

Long-term growth metrics also paint a subdued picture. Over the past five years, net sales have grown at an annualised rate of 9.80%, while operating profit growth has been even more modest at 2.86% per annum. These growth rates are below what many investors would expect from a company in the industrial products sector, especially given the competitive landscape.

Valuation: Discounted but Expensive Relative to Returns

Borosil Scientific’s valuation presents a mixed scenario. The stock trades at a Price to Book (P/B) ratio of 2.6, which is considered expensive given the company’s low ROE and modest growth profile. However, this valuation is still at a discount compared to its peers’ historical averages, suggesting some relative value for investors willing to look beyond headline multiples.

Over the past year, the stock has underperformed the broader market, delivering a negative return of -16.63%, compared to the BSE500’s decline of -2.09%. Despite this underperformance, the company’s profits have risen by 11% over the same period, indicating a disconnect between earnings growth and share price movement. This divergence may reflect investor scepticism about the company’s growth prospects or concerns about liquidity and market interest, as evidenced by the very low domestic mutual fund holding of just 0.04%.

Returns Compared to Sensex and Market Benchmarks

Examining Borosil Scientific’s returns relative to the Sensex reveals a nuanced picture. The stock outperformed the Sensex over the past week with a 2.95% gain versus the Sensex’s 0.86%. Over the past month, it marginally outperformed with a 0.21% return compared to the Sensex’s -4.19%. Year-to-date, the stock’s decline of -1.04% is significantly better than the Sensex’s -11.76% fall, indicating some resilience in volatile markets.

However, over the one-year horizon, Borosil Scientific’s -16.63% return lags the Sensex’s -8.36%, highlighting recent underperformance. Longer-term data is not available for the stock, but the Sensex’s 10-year return of 196.07% underscores the challenges faced by this micro-cap in delivering sustained growth.

Summary and Outlook

The upgrade of Borosil Scientific Ltd’s investment rating from Sell to Hold by MarketsMOJO reflects a balanced assessment of recent developments. The company’s technical indicators have improved, signalling a potential shift in market sentiment. Financially, the return to profitability and net-debt-free status provide a solid foundation for stability.

Nonetheless, challenges remain in terms of management efficiency, long-term growth, and valuation metrics. The stock’s underperformance relative to the broader market and low institutional interest suggest that investors should approach with caution. The Hold rating indicates that while the stock is no longer a sell, it does not yet warrant a Buy recommendation given the current fundamentals and market conditions.

Investors should monitor upcoming quarterly results and technical trends closely to gauge whether Borosil Scientific can sustain its positive momentum and improve its growth trajectory.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today